Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, The People's Republic of China.
Exp Neurol. 2012 Dec;238(2):235-42. doi: 10.1016/j.expneurol.2012.08.014. Epub 2012 Aug 19.
Repulsive guidance molecule a (RGMa) is a neurite growth inhibitor that is of great interest in the study of CNS neuronal regeneration. We adopted RNA interference (RNAi) as a means of suppressing the expression of RGMa and observed the improvement in axonal regeneration and neurological function of rats after cerebral ischemic injury. Recombinant adenovirus rAd5-shRNA-RGMa was constructed and prepared for animal experimentation. RGMa and neurofilament protein 200 (NF200) in the ischemic cortex and ipsilateral hippocampus were detected by reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry. The ischemic regions were examined by triphenyltetrazolium chloride (TTC) staining and the newborn neurite branches by Biotinylated Dextran Amine (BDA) neuronal tracing. Behavior tests were adopted to evaluate neurologic function recovery. Results showed RGMa was down-regulated and axonal growth was improved in the RNAi treated group (P<0.01). The number of axonal sprouts of corticospinal tract from the uninjured side to the ischemic side in the RNAi treated group was increased (P<0.01). Behavior test scores in the RNAi treated group were significantly better than other groups after 6 weeks (P<0.01). RGMa in rat brains after middle cerebral artery occlusion (MCAO) can be down-regulated by RNAi successfully, which may lead to improved axonal growth and neural anatomy plasticity, as well as neuron functional recovery.
repulsive 导向分子 a (RGMa) 是一种神经突生长抑制剂,在中枢神经系统神经元再生的研究中具有重要意义。我们采用 RNA 干扰 (RNAi) 作为抑制 RGMa 表达的手段,观察到脑缺血损伤后大鼠轴突再生和神经功能的改善。构建并制备了重组腺病毒 rAd5-shRNA-RGMa 进行动物实验。采用逆转录聚合酶链反应 (RT-PCR) 和免疫组织化学检测缺血皮质和同侧海马中的 RGMa 和神经丝蛋白 200 (NF200)。采用氯化三苯基四氮唑 (TTC) 染色和生物素化葡聚糖胺 (BDA) 神经元追踪检测缺血区。采用行为测试评估神经功能恢复情况。结果显示,RNAi 处理组 RGMa 下调,轴突生长改善 (P<0.01)。RNAi 处理组损伤侧皮质脊髓束的轴突芽数量增加 (P<0.01)。6 周后,RNAi 处理组行为测试评分明显优于其他组 (P<0.01)。RNAi 可成功下调大脑中动脉闭塞 (MCAO) 后大鼠脑中的 RGMa,可能导致轴突生长和神经解剖可塑性改善,以及神经元功能恢复。